← All trials
NCT06082596
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 2, 2016
- Primary completion
- Mar 8, 2019
- Completion date
- Mar 8, 2019
- First posted
- Oct 13, 2023
- Last posted
- Oct 13, 2023
- Enrollment
- 32
- Arms / groups
- 7 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Guangzhou BeBetter Medicine Technology Co, LTDLead sponsor
- Central South UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.